Predictive Oncology Inc. — Director's Dealing 2025

Sep 11, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2025-09-09

Reporting Person: Hawryluk Matthew (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-09	Common Stock	A	64680	$0.00	Acquired	74168	Direct

Footnotes

F1: The grant consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs shall vest in full on October 31, 2025, subject to continued service through the applicable vesting date.